{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:52:53Z","timestamp":1791582773652,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["AC22\/00026"],"award-info":[{"award-number":["AC22\/00026"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI25\/00041"],"award-info":[{"award-number":["PI25\/00041"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020082","name":"Navarra Government General Directorate of Industry Energy and Strategic Projects S3","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020082","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018779","name":"Fero Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018779","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016120","name":"Government of Navarre Department of Health","doi-asserted-by":"publisher","award":["GN2024\/11"],"award-info":[{"award-number":["GN2024\/11"]}],"id":[{"id":"10.13039\/501100016120","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017642","name":"National Plan for Scientific and Technical Research and Innovation","doi-asserted-by":"publisher","award":["PID2023-147515OB-I00"],"award-info":[{"award-number":["PID2023-147515OB-I00"]}],"id":[{"id":"10.13039\/501100017642","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006671","name":"Caja Navarra Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006671","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007320","name":"Albert Einstein Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002704","name":"Spanish Association Against Cancer Scientific Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002704","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.imbio.2026.153205","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T17:58:29Z","timestamp":1781200709000},"page":"153205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Monomethyl-auristatin E-based anti-CD137 (4-1BB) antibody drug conjugates are not suitable tools to deplete activated T lymphocytes"],"prefix":"10.1016","volume":"231","author":[{"given":"Gabriel","family":"Gomis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saioa","family":"Arrieta-Aranzueque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Herrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arantza","family":"Azpilikueta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Molero-Glez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Cuesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Streitlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Kleist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Mier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda J.","family":"Garrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Rochira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Pineda-Lucena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Berraondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Melero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2026.153205_bb0005","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1084\/jem.20011481","article-title":"c-Jun NH(2)-terminal kinase (JNK)1 and JNK2 signaling pathways have divergent roles in CD8(+) T cell-mediated antiviral immunity","volume":"195","author":"Arbour","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2026.153205_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2015.00117","article-title":"4-1BB agonists: multi-potent potentiators of tumor immunity","volume":"5","author":"Bartkowiak","year":"2015","journal-title":"Front. Oncol."},{"key":"10.1016\/j.imbio.2026.153205_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/cells8101294","article-title":"Tubulin: structure, functions and roles in disease","volume":"8","author":"Binarova","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.imbio.2026.153205_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117780","article-title":"Dynamic P-glycoprotein expression in early and late memory states of human CD8\u00a0+\u00a0T cells and the protective role of ruxolitinib","volume":"182","author":"Biwott","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.imbio.2026.153205_bb0025","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.immuni.2018.09.014","article-title":"Antibodies to Costimulatory Receptor 4-1BB Enhance Anti-tumor Immunity via T Regulatory Cell Depletion and Promotion of CD8 T Cell Effector Function","volume":"49","author":"Buchan","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.imbio.2026.153205_bb0030","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1073\/pnas.251664698","article-title":"Structural basis of transcription: alpha-amanitin-RNA polymerase II cocrystal at 2.8 a resolution","volume":"99","author":"Bushnell","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.imbio.2026.153205_bb0035","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s40265-019-01175-0","article-title":"Polatuzumab Vedotin: First Global Approval","volume":"79","author":"Deeks","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.imbio.2026.153205_bb0040","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s13075-024-03452-0","article-title":"Therapeutic potential of antibody-drug conjugates possessing bifunctional anti-inflammatory action in the pathogenies of rheumatoid arthritis","volume":"26","author":"Dixit","year":"2024","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.imbio.2026.153205_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262311761","article-title":"CD74-Targeting Antibody-Drug Conjugate Enhances Immunosuppression of Glucocorticoid in Systemic Lupus Erythematosus","volume":"26","author":"Du","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.imbio.2026.153205_bb0050","article-title":"New emerging targets in cancer immunotherapy: CD137\/4-1BB costimulatory axis","volume":"4","author":"Etxeberria","year":"2020","journal-title":"ESMO Open"},{"key":"10.1016\/j.imbio.2026.153205_bb0055","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1172\/JCI128672","article-title":"A conserved intratumoral regulatory T cell signature identifies 4-1BB as a pan-cancer target","volume":"130","author":"Freeman","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imbio.2026.153205_bb0060","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41392-022-00947-7","article-title":"Antibody drug conjugate: the \u201cbiological missile\u201d for targeted cancer therapy","volume":"7","author":"Fu","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.imbio.2026.153205_bb0065","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1182\/blood.2024027239","article-title":"A single dose of a CD137 antibody-drug conjugate protects rhesus macaque allogeneic HCT recipients against acute GVHD","volume":"146","author":"Gerdemann","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2026.153205_bb0070","doi-asserted-by":"crossref","first-page":"7063","DOI":"10.1158\/1078-0432.CCR-04-0789","article-title":"Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate","volume":"10","author":"Hamblett","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.imbio.2026.153205_bb0075","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.4049\/jimmunol.169.9.4882","article-title":"4-1BB promotes the survival of CD8+ T lymphocytes by increasing expression of Bcl-xL and Bfl-1","volume":"169","author":"Lee","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2026.153205_bb0080","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/cei.12152","article-title":"Activation-induced CD137 is a fast assay for identification and multi-parameter flow cytometric analysis of alloreactive T cells","volume":"174","author":"Litjens","year":"2013","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.imbio.2026.153205_bb0085","doi-asserted-by":"crossref","first-page":"6694","DOI":"10.4049\/jimmunol.1203010","article-title":"T cell costimulation with anti-CD137 monoclonal antibodies is mediated by K63-polyubiquitin-dependent signals from endosomes","volume":"190","author":"Martinez-Forero","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2026.153205_bb0090","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nm0697-682","article-title":"Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors","volume":"3","author":"Melero","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.imbio.2026.153205_bb0095","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1158\/2159-8290.CD-22-1029","article-title":"CD137 (4-1BB)-based Cancer Immunotherapy on its 25th anniversary","volume":"13","author":"Melero","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.imbio.2026.153205_bb0100","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1158\/2326-6066.CIR-14-0216","article-title":"Virotherapy with a Semliki Forest Virus-based Vector Encoding IL12 Synergizes with PD-1\/PD-L1 Blockade","volume":"3","author":"Quetglas","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.imbio.2026.153205_bb0105","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1084\/jem.186.1.47","article-title":"4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses","volume":"186","author":"Shuford","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2026.153205_bb0110","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1006\/cimm.1998.1433","article-title":"Differential expression and costimulatory effect of 4-1BB (CD137) and CD28 molecules on cytokine-induced murine CD8(+) Tc1 and Tc2 cells","volume":"192","author":"Vinay","year":"1999","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.imbio.2026.153205_bb0115","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa1814017","article-title":"Trastuzumab Emtansine for Residual Invasive HER2-positive Breast Cancer","volume":"380","author":"von Minckwitz","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imbio.2026.153205_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160890","article-title":"Structural basis of microtubule destabilization by potent auristatin anti-mitotics","volume":"11","author":"Waight","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.imbio.2026.153205_bb0125","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1182\/blood-2006-11-056168","article-title":"Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities","volume":"110","author":"Wolfl","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2026.153205_bb0130","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s41419-019-1980-8","article-title":"An anti-CD103 antibody-drug conjugate prolongs the survival of pancreatic islet allografts in mice","volume":"10","author":"Xue","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.imbio.2026.153205_bb0135","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/j.ymthe.2024.03.032","article-title":"Anti-CD45 PBD-based antibody-drug conjugates are effective targeted conditioning agents for gene therapy and stem cell transplant","volume":"32","author":"Yeung","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.imbio.2026.153205_bb0140","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1182\/blood-2006-10-043463","article-title":"CD137 stimulation delivers an antigen-independent growth signal for T lymphocytes with memory phenotype","volume":"109","author":"Zhu","year":"2007","journal-title":"Blood"}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298526000513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298526000513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:08:27Z","timestamp":1791580107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298526000513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0171298526000513"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2026.153205","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monomethyl-auristatin E-based anti-CD137 (4-1BB) antibody drug conjugates are not suitable tools to deplete activated T lymphocytes","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2026.153205","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"153205"}}